Session 200 – Strategies for Optimal Risk Management
10.25 Chair
Steven Walfish, President, Statistical Outsourcing Services
10.30 Defining and Controlling your Design: Setting Yourself Up for Success!
Gary Fahey, Design Control Manager, Abbott Ireland
11.15 MES - The Benefits to Compliance and Operations Management. How eManufacturing Mitigates Risk in Medical Device Manufacture
Mark McKechnie, Prinicpal Consultant, Seabrook Research
12.00 Integrating Operational Excellence and Risk Management Approaches; Tools for Achieving Breakthrough in Economic Medical Device Manufacturing
Eoin Barry, Founder and Director, ARV Excellence
12.45 Lunch
14.00 Usability Engineering: Process and Validation - Understanding Usability Standards for Medical Devices
Niall Murphy, Consultant, PanelSoft
14.45 Robust Design to Minimize Risk – Part 1
Steven Walfish, Statistical Outsourcing Services
15.30 Break
15.45 Robust Design to Minimize Risk – Part 2
Steven Walfish, Statistical Outsourcing Services
16.30 End |
Session 201 - Innovation
10.25 Chair
Michael Loftus, Consultant, Loftus Consulting
10.30 Strategic Change – Alignment with Opportunities
Michael Loftus, Consultant, Loftus Consulting
11.00 Understanding the Clinical Needs
Each speaker will give a 10/15 minute presentation
Professor John O’Byrne, Consultant Orthopaedics, Cappagh National Orthopedic Hospital
Professor David Foley, Surgeon, Dept. of Cardiology, Beaumont Hospital
Eibhlin Mulroe, CEO, Irish Platform for Patients’ Organisations, Science & Industry (IPPOSI)
11.45 Development and Approvals
Kieran Ryan, Surgical Research Manager, Surgical R&D Committee, Dept of Surgical Affairs, Royal College of Surgeons, Ireland (RCSI)
12.25 Open Q&A (with morning speakers)
12.45 Lunch
13.45 Technology Transfer at RCSI
Derek Young, Head of Surgical Innovation Centre, Royal College of Surgeons in Ireland
14.15 Regulatory Challenges and Strategies for Medical Device Entrepreneurs
Derval O’Carroll, Director, Real Regulatory
14.45 Network and Research Funding
Each speaker will give a 15 minute presentation
Dr Liz Moran, Senior Biotechnology Analyst, Enterprise Ireland Lifescience & Food Commercialisation Group (EI Bio)
Tom Kelly, Manager of the Environment, Industrial and Life Sciences, Enterprise Ireland
Richard Hendron, Manager Medical Technologies Division, Industrial Development Agency (IDA) Ireland
15.15 Break
15.30 Functional Lumen Imaging Probe (FLIP) - From Research Tool to Commercial Medical Device
Jonathan Bouchier-Hayes, Director of Business Development, Crospon
16.00 The Science of Innovation
Damian Costello, Operations Director, Systematic Innovation
16.30 End |